Submissions from 2021
Intercourse frequency among men presenting to a sexual health clinic: does age matter?, Mary E. Westerman, Francisco Maldonado, Jack R. Andrews, Vidit Sharma, Landon Trost, and Matthew J. Ziegelmann
Impact of CoVID-19 on resident and fellow education: Current guidance and future opportunities for urologic oncology training programs, Mary E. Westerman, Alexandra L. Tabakin, Wade J. Sexton, Brian F. Chapin, and Eric A. Singer
Submissions from 2020
Treatment of non-obstructive, non-struvite urolithiasis is effective in treatment of recurrent urinary tract infections, Deepak K. Agarwal, Amy E. Krambeck, Vidit Sharma, Francisco J. Maldonado, Mary E. Westerman, John J. Knoedler, and Marcelino E. Rivera
What Factors Are Associated With Implant Failure?, Michael S. Block, Brian J. Christensen, Don E. Mercante, and Andrew G. Chapple
Risk of abnormal cervical cytology in HIV-infected women testing positive for both human papillomavirus and Epstein-Barr virus in genital tract specimens, Jennifer E. Cameron, D'Antoni C. Dennis, Nicholas R. Herrel, Andrew G. Chapple, and Michael E. Hagensee
A novel Bayesian continuous piecewise linear log-hazard model, with estimation and inference via reversible jump Markov chain Monte Carlo, Andrew G. Chapple, Taylor Peak, and Ashok Hemal
Comparison of Phase I-II designs with parametric or semi-parametric models using two different risk-benefit trade-off criteria, Andrew G. Chapple and Peter F. Thall
Healthy pregnancies and essential fats: focus group discussions with Zambian women on dietary need and acceptability of a novel RUSF containing fish oil DHA, Catherine Chunda-Liyoka, Mwansa Ketty Lubeya, Mercy Imakando, Sophia Kisling, Sonoor Majid, Mary S. Willis, Charles Wood, Chipepo Kankasa, and Concetta C. DiRusso
Intravenous 5-fluoro-2'-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors, Geraldine O. Coyne, Lihua Wang, Jennifer Zlott, Lamin Juwara, Joseph M. Covey, Jan H. Beumer, Mihaela C. Cristea, Edward M. Newman, Stephen Koehler, Jorge J. Nieva, Agustin A. Garcia, David R. Gandara, Brandon Miller, Sonny Khin, Sarah B. Miller, Seth M. Steinberg, Larry Rubinstein, Ralph E. Parchment, Robert J. Kinders, Richard L. Piekarz, Shivaani Kummar, Alice P. Chen, and James H. Doroshow
A New Approach to Analyzing Regenerated Bone Quality in the Mouse Digit Amputation Model Using Semi-Automatic Processing of microCT Data, Kevin F. Hoffseth, Jennifer Simkin, Emily Busse, Kennon Stewart, James Watt, Andrew Chapple, Aaron Hargrove, and Mimi C. Sammarco
How the Cervical Microbiota Contributes to Cervical Cancer Risk in Sub-Saharan Africa, Cameron Klein, Crispin Kahesa, Julius Mwaiselage, John T. West, Charles Wood, and Peter C. Angeletti
ANG1005, a Brain-Penetrating Peptide-Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases, Priya Kumthekar, Shou-Ching Tang, Andrew J. Brenner, Santosh Kesari, David E. Piccioni, Carey Anders, Jose Carrillo, Pavani Chalasani, Peter Kabos, Shannon Puhalla, Katherine Tkaczuk, Agustin A. Garcia, Manmeet S. Ahluwalia, Jeffrey S. Wefel, Nehal Lakhani, and Nuhad Ibrahim
HIV-1 subtypes and drug resistance mutations among female sex workers varied in different cities and regions of the Democratic Republic of Congo, Eun Hee Kwon, Godefroid M. Musema, Jessica Boelter, Sydney Townsend, Désiré Tshala-Katumbay, Patrick K. Kayembe, John West, and Charles Wood
Neonatal Survivability following Previable PPROM after Hospital Readmission for Intervention, Felicia LeMoine, Robert C. Moore, Andrew Chapple, Ferney A. Moore, and Elizabeth Sutton
Comparative transcriptome analysis of endemic and epidemic Kaposi's sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis, Salum J. Lidenge, Andrew V. Kossenkov, For Yue Tso, Jayamanna Wickramasinghe, Sara R. Privatt, Owen Ngalamika, John R. Ngowi, Julius Mwaiselage, Paul M. Lieberman, John T. West, and Charles Wood
Prevalence of Kaposi's sarcoma-associated herpesvirus and transfusion-transmissible infections in Tanzanian blood donors, Salum J. Lidenge, Tara Tran, For Yue Tso, John R. Ngowi, Danielle M. Shea, Julius Mwaiselage, Charles Wood, and John T. West
Viral and Immunological Analytes are Poor Predictors of the Clinical Treatment Response in Kaposi's Sarcoma Patients, Salum J. Lidenge, For Yue Tso, Yasaman Mortazavi, John R. Ngowi, Danielle M. Shea, Julius Mwaiselage, Charles Wood, and John T. West
Lack of CD8 T-cell co-localization with Kaposi's sarcoma-associated herpesvirus infected cells in Kaposi's sarcoma tumors, Salum J. Lidenge, For Yue Tso, Owen Ngalamika, Jaydeep Kolape, John R. Ngowi, Julius Mwaiselage, Charles Wood, and John T. West
The Kaposi's Sarcoma-Associated Herpesvirus (KSHV) gH/gL Complex Is the Predominant Neutralizing Antigenic Determinant in KSHV-Infected Individuals, Yasaman Mortazavi, Salum J. Lidenge, Tara Tran, John T. West, Charles Wood, and For Yue Tso
Outcome markers of ART-treated HIV+ patients with early stage Kaposi's sarcoma, Owen Ngalamika, For Yue Tso, Salum Lidenge, Sody Munsaka, Danielle Shea, Charles Wood, and John West
An Update on Screening and Prevention for Breast and Gynecological Cancers in Average and High Risk Individuals, Anahid M. Pahlawanian, Vanessa A. Norris, Amelia M. Jernigan, Brooke Morrell, Mignonne Morrell, Navya Nair, Amber M. Karamanis, Erin M. Dauchy, Michelle M. Loch, and Agustin A. Garcia
Relationships Between Maternal Antibody Responses and Early Childhood Infection With Kaposi Sarcoma-Associated Herpesvirus, Lisa K. Poppe, Chipepo Kankasa, Charles Wood, and John T. West
The Presence of Antibody-Dependent Cell Cytotoxicity-Mediating Antibodies in Kaposi Sarcoma-Associated Herpesvirus-Seropositive Individuals Does Not Correlate with Disease Pathogenesis or Progression, Lisa K. Poppe, Charles Wood, and John T. West
Sunscreen Knowledge Amongst Rheumatologists: Finding the Gap, Ainsley Pratt, John Scheinuk, Dasha Lopez, Christopher J. Mesa, Soham Mahato, Andrew G. Chapple, and Myriam E. Guevara
Cytoreductive Nephrectomy in Patients Presenting With Advanced Disease: Have We Finally Answered the Question?, Daniel D. Shapiro, Mary E. Westerman, Jose A. Karam, and Christopher G. Wood
Clinical Characteristics and Outcomes Based on Race of Hospitalized Patients With COVID-19 in a New Orleans Cohort, Victoria Silver, Andrew G. Chapple, Allison H. Feibus, Jeremy Beckford, Natalie A. Halapin, Delphi Barua, Angellica Gordon, Will Baumgartner, Seth Vignes, Cullen Clark, Sanjay Kamboj, Stephen C. Lim, Scott P. Mackey, Paula S. Seal, Joseph M. Kanter, Caryn Bell, and Meredith E. Clement
Origin of Subsequent Malignant Neoplasms in Patients with History of Testicular Germ Cell Tumor, Eric C. Umbreit, Bilal A. Siddiqui, Michael J. Hwang, Aron Y. Joon, Tapati Maity, Mary E. Westerman, Kelly W. Merriman, Hussam Alhasson, Joma Uthup, Tao Guo, Joseph A. Moore, John F. Ward, Jose A. Karam, Christopher G. Wood, Louis L. Pisters, Miao Zhang, and Shi-Ming Tu
Second-line lenvatinib in patients with recurrent endometrial cancer, Ignace Vergote, Matthew A. Powell, Michael G. Teneriello, David S. Miller, Agustin A. Garcia, Olga N. Mikheeva, Mariusz Bidzinski, Cristina Ligia Cebotaru, Corina E. Dutcus, Min Ren, Tadashi Kadowaki, Yasuhiro Funahashi, and Richard T. Penson
Radical Cystectomy and Perioperative Sexual Function: A Cross-Sectional Analysis, Mary E. Westerman, Andrea Kokorovic, Xin Shelly Wang, Amy Lim, Araceli Garcia-Gonzalez, Mohamed Seif, Run Wang, Ashish M. Kamat, Colin P. Dinney, and Neema Navai
Survival following cytoreductive nephrectomy: a comparison of existing prognostic models, Mary E. Westerman, Daniel D. Shapiro, Nizar M. Tannir, Matthew T. Campbell, Surena F. Matin, Jose A. Karam, and Christopher G. Wood
Neoadjuvant Therapy for Locally Advanced Renal Cell Carcinoma, Mary E. Westerman, Daniel D. Shapiro, Christopher G. Wood, and Jose A. Karam
Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study, Anna H. Wu, Chiuchen Tseng, Cheryl Vigen, Yang Yu, Wendy Cozen, Agustin A. Garcia, and Darcy Spicer
Submissions from 2018
Subgroup-specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination, Andrew G. Chapple and Peter F. Thall